Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Theralase Technologies Inc

TLT.V ✗ NOT COMPLIANT ☆ Track — members

TSX Venture · Healthcare · Advanced Medical Equipment & Technology ·

Canada Micro Cap Analyst: BUY

Last Close

$0.14

▲ +2.70%

Market Cap $35.36M · Vol 7.23K

Key Metrics

P/E Ratio

N/A

FWD: 18.44

Market Cap

$35.36M

Micro Cap

Div Yield

N/A

EPS Growth

+38.05%

YoY

RSI (14)

57.14

Momentum

Beta

0.41

vs Market

52W High

$0.30

54.30% below

52W Low

$0.10

30.58% above

Volume

7.23K

Avg 356.80K

P/B

24.60

Price-to-book

ROE

N/A

Return on equity

Free Float

91.53%

Public shares

Shariah Compliance8 STANDARDS

✗ Theralase Technologies Inc (TLT.V) stock is currently not Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See which standards it fails, the exact ratios behind the verdict, and halal alternatives. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does TLT.V pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+5.56%

-28.30%

-22.45%

-29.63%

YTD

+15.15%

+0.00%

-18.43%

-17.39%

Financials & Valuation

TTM · Annual

Total Revenue	$594.92K
Net Income	$-3,002,638.00
Revenue Growth (YoY)	-25.23%
Gross Margin	62.11%
Operating Margin	-511.39%
Net Profit Margin	-504.71%
ROE	N/A
ROA · ROIC	-122.25% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	18.44
PEG Ratio	N/A
P/S	51.16
P/B	24.60
P/FCF	N/A
EPS Growth	+38.05%
Outstanding Shares	257.06M

Technical Indicators

50-Day SMA	$0.17
200-Day SMA	$0.18
RSI (14)	57.14
Beta	0.41
52-Week High	$0.30
52-Week Low	$0.10

Volume Today	7.23K
Avg Daily Volume (30D)	356.80K
Relative Volume	0.02x
Volatility (10D)	46.93
Volatility (30D)	87.84
Free Float	91.53%

Analyst Consensus

BUY

Current Price $0.14

Mean Target $0.51

52W Low$0.10 52W High$0.30

Current

Target

$0.10 $0.30

Current Analyst target

+270.22% upside potential · 1 analysts

Identifiers

ExchangeTSX Venture

FIGIBBG001S5Z630

ISINCA88337V1004

CountryCanada

Sub-IndustryLaser Equipment

Earnings DateNov 9, 2026

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

ELN.MI El En SpA +0.80% AERG Applied Energetics Inc +5.02% TMO Thermo Fisher Scientific Inc -1.75% DHR Danaher Corp -1.17% ISRG Intuitive Surgical Inc -4.51%

Company Profile

Theralase Technologies Inc. is a Canada-based clinical stage pharmaceutical company. The Company is engaged in the research and development of light, radiation, sound and drug-activated small molecule compounds and their associated formulations, with a primary objective of efficacy and a secondary objective of safety in the destruction of various cancers, bacteria and viruses, with minimal impact on surrounding healthy tissue. It operates through two divisions: the Drug Division and the Device Division. The Drug Division is responsible for the research and development of small molecules primarily for the treatment of cancer with assistance from the Device Division to develop medical lasers to activate them. The Device Division is responsible for the Company’s medical laser business, which researches, develops, manufactures and distributes cool laser therapy systems to healthcare practitioners, predominantly for the healing of pain.